I suppose big pharma would like to monopolize the engines for individuated cancer vaccines. And this article is trying to advocate a way out of that pattern.
Other countries though will develop their own personalize-able vaccine engines and will avoid FDA approvals and the game will be kinda over for big pharma monopoly in this.
I suppose big pharma would like to monopolize the engines for individuated cancer vaccines. And this article is trying to advocate a way out of that pattern.
Other countries though will develop their own personalize-able vaccine engines and will avoid FDA approvals and the game will be kinda over for big pharma monopoly in this.